% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • btimnextmicrosoft btimnextmicrosoft Jun 17, 2013 1:40 PM Flag


    NEW YORK, NY June 17, 2013 / -- IntelliCell BioSciences, Inc. ("Company") (OTC PINK: SVFC) announced today that Dr Zain Khalpey, MD, PhD, MRCS (Eng) Director, Heart Transplant Program & Mechanical Circulatory Support, Division of Cardiothoracic SurgeryAssociate Professor of Surgery, Physiological Sciences & Biomedical Engineering, University of Arizona College of Medicine has joined the Advisory Board.
    Dr. Steven Victor, CEO of IntelliCell stated, "We are very pleased to have Dr Khalpey join our Advisory Board and help the company advance the use of its patented technology in the area of cardiac diseases. Dr Khalpey has the passion for regenerative medicine that will help propel the use of stem cells in the cardiothoracic world. We are excited to be able to work with such a brilliant cardiac surgeon and researcher. We believe that through our association with Dr. Khalpey and the UA, we will be able to help numerous cardiac and lung patients with unmet clinical needs.”
    Dr Khalpey “I would rather not put you on the list for transplant, I would rather take your fat-derived stem cells, inject them into you and try to use the device as a bridge to regenerate your heart, rather than using transplanted tissue, where you have to be on immunosuppression for the rest of your life. I believe that with the use of cavitation technology to harvest the stromal vascular fraction from a lipoaspirate without chemicals and enzymes, we would be able to capture the appropriate stem cells with their micromatrix and microenvironment for use in patients with failing hearts and lungs.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • In addition to his clinical work at The University of Arizona Medical Center, where he recently was appointed director of the internationally renowned heart transplant program and mechanical circulatory support, Khalpey is involved in numerous research activities, focused mainly in three key areas: bridge to regeneration, organ reconditioning and organogenesis, or the creation of new organs.

0.00010.0000(0.00%)Sep 23 3:50 PMEDT